These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3009061

  • 1. Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: normal EBV-specific HLA-restricted cytotoxicity.
    Rousset F, Souillet G, Roncarolo MG, Lamelin JP.
    Clin Exp Immunol; 1986 Feb; 63(2):280-9. PubMed ID: 3009061
    [Abstract] [Full Text] [Related]

  • 2. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG, Szigeti R, Ernberg I, Masucci G, Klein G, Chessels J, Sieff C, Lie S, Glomstein A, Businco L, Henle W, Henle G, Pearson G, Sakamoto K, Purtilo DT.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [Abstract] [Full Text] [Related]

  • 3. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
    Grierson HL, Skare J, Hawk J, Pauza M, Purtilo DT.
    Am J Med Genet; 1991 Sep 01; 40(3):294-7. PubMed ID: 1683154
    [Abstract] [Full Text] [Related]

  • 4. Analysis of cellular immune response to EBV by using cloned T cell lines.
    Slovin SF, Schooley RT, Thorley-Lawson DA.
    J Immunol; 1983 May 01; 130(5):2127-32. PubMed ID: 6187840
    [Abstract] [Full Text] [Related]

  • 5. A family study of the X-linked lymphoproliferative syndrome: evidence for a B cell defect contributing to the immunodeficiency.
    Ando I, Morgan G, Levinsky RJ, Crawford DH.
    Clin Exp Immunol; 1986 Feb 01; 63(2):271-9. PubMed ID: 3009060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pathophysiologic analysis of peripheral blood lymphocytes from patients with primary immunodeficiency. I. Ig synthesis by peripheral blood lymphocytes stimulated with either pokeweed mitogen or Epstein-Barr virus in vitro.
    Mitsuya H, Osaki K, Tomino S, Katsuki T, Kishimoto S.
    J Immunol; 1981 Jul 01; 127(1):311-5. PubMed ID: 6263975
    [Abstract] [Full Text] [Related]

  • 9. Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immunoregulatory T cell defects.
    Lindsten T, Seeley JK, Ballow M, Sakamoto K, St Onge S, Yetz J, Aman P, Purtilo DT.
    J Immunol; 1982 Dec 01; 129(6):2536-40. PubMed ID: 6292291
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP).
    Tatsumi E, Purtilo DT.
    AIDS Res; 1986 Dec 01; 2 Suppl 1():S109-13. PubMed ID: 3030340
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M, Benninger-Döring G, Prang N, Sylla BS, Laumbacher B, Wank R, Wolf H, Schwarzmann F.
    Int J Cancer; 1998 May 29; 76(5):694-701. PubMed ID: 9610728
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.
    Int J Oncol; 2004 May 29; 24(5):1165-74. PubMed ID: 15067338
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
    Tanaka Y, Sugamura K, Hinuma Y.
    J Immunol; 1982 Mar 29; 128(3):1241-5. PubMed ID: 6173428
    [Abstract] [Full Text] [Related]

  • 14. X-linked lymphoproliferative syndrome.
    Sullivan JL, Woda BA.
    Immunodefic Rev; 1989 Mar 29; 1(4):325-47. PubMed ID: 2561059
    [Abstract] [Full Text] [Related]

  • 15. Imbalance of the Epstein-Barr virus-host relationship in AIDS-related complex patients.
    Ragona G, Sirianni MC.
    Cancer Detect Prev Suppl; 1987 Mar 29; 1():549-52. PubMed ID: 2826004
    [Abstract] [Full Text] [Related]

  • 16. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
    Okano M.
    Hokkaido Igaku Zasshi; 1986 Jul 29; 61(4):584-92. PubMed ID: 3019855
    [Abstract] [Full Text] [Related]

  • 17. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.
    Q J Med; 1986 Feb 29; 58(226):111-21. PubMed ID: 3012622
    [Abstract] [Full Text] [Related]

  • 18. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects.
    Harada S, Sakamoto K, Seeley JK, Lindsten T, Bechtold T, Yetz J, Rogers G, Pearson G, Purtilo DT.
    J Immunol; 1982 Dec 29; 129(6):2532-5. PubMed ID: 6292290
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A, Ito Y, Akatsuka Y, Tsujimura K, Morishima Y, Takahashi T, Kuzushima K.
    Eur J Immunol; 2006 Mar 29; 36(3):593-602. PubMed ID: 16479544
    [Abstract] [Full Text] [Related]

  • 20. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
    Katsuki T, Yamaguchi K, Matsuoka Y, Hinuma Y.
    AIDS Res; 1986 Dec 29; 2 Suppl 1():S125-30. PubMed ID: 3030343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.